Profiel
Jennifer Dudinak served as the Senior Vice President-Global Regulatory Affairs at Celgene Corp.
from 2018 to 2019.
She received her undergraduate and doctorate degrees from Rutgers University, Camden.
Eerdere bekende functies van Jennifer Dudinak
| Bedrijven | Functie | Einde |
|---|---|---|
| CELGENE | General Counsel | 01-10-2019 |
Opleiding van Jennifer Dudinak
| Rutgers University, Camden | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
